Status:
RECRUITING
Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
Lead Sponsor:
Rush University Medical Center
Conditions:
Osteoarthritis of the Knee
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthri...
Detailed Description
The purpose of this study is to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis and compare that to patients receiving corticosteroid inj...
Eligibility Criteria
Inclusion
- Patients between the ages of 18-70
- Long standing knee pain from osteoarthritis (KL grade 2-3) despite conventional treatments such as activity modification, weight loss, physical therapy, analgesics, nonsteroidal anti-inflammatory drugs, or injection therapy for at least 6 weeks
- 7-day average pain score of at least 4 on VAS scale
Exclusion
- Systemic diseases (Diabetes, malignancies, infections, etc.)
- Post-traumatic arthritis
- Patient had intra-articular injection on affected knee in last three months
Key Trial Info
Start Date :
July 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05985785
Start Date
July 19 2022
End Date
March 31 2028
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612